‘Ivejaj’ Tablets for COVID-19 Treatment

Published on May 07, 2021
Current Context: Bajaj Healthcare Limited has announced the launch of ‘Ivejaj’ (Ivermectin) which is an Anti-Parasitic Drug used in control & offers treatment for Covid-19 patients.
‘Ivejaj’ Tablets for COVID-19 Treatment
  • The company has also received approval from India's drug regulator, DCGI to manufacture and market ‘Ivejaj’.
  • Bajaj Healthcare Limited has developed the active pharmaceutical ingredient and the formulation for Ivermectin through its R&D team.

Question: 

Q.1 Which organisation developed ‘Ivejaj’ (Ivermectin) which is an Anti-Parasitic Drug used in control & offers treatment for Covid-19 patients?
a. Syncom Healthcare
b. Eris Lifesciences
c. Bajaj Healthcare Limited
d. Parabolic Drugs Ltd.
Labels:

Can I help you?

ramandeep singh

Hey I am Ramandeep Singh. I am determined to help students preparing for RBI, SEBI, NABARD and IBPS exams. Do you want me to help you ?

Join my class here
    Follow me:
Close Menu
Close Menu